Raporo iheruka ya #OMS igaragaza ukuri gukomeye: miliyoni 8.2 z'abarwayi bashya ba TB bagaragaye mu 2023—ni ukuvuga umubare munini kuva aho igenzura mpuzamahanga ryatangiriye mu 1995. Uku kwiyongera kuva kuri miliyoni 7.5 mu 2022 kwasubije igituntu nk'icya mbere.indwara zandura zihitana abantu benshi, irenga COVID-19.
Nyamara, ikibazo gikomeye kurushaho gihishe uku kugaruka kwacyo:ubudahangarwa bw'imiti irwanya udukoko (AMR)OMS iteganya ko mu 2050, AMR ishobora kwitwaza koubuzima bw'abantu bagera kuri miliyoni 10 buri mwakaku isi yose, aho igituntu kidakira imiti (DR-TB) ari cyo kintu gikomeye cyagize ingaruka mbi. Mu 2019 gusa, AMR yishe abantu miliyoni 1.3 mu buryo butaziguye—kurenza VIH/SIDA na malariya hamwe—kandi ubu niimpamvu ya gatatu y'urupfu ku isiHatabayeho igikorwa, impfu nyinshi zikomoka kuri AMR zishobora kugera kuriMiliyoni 39 bitarenze umwaka wa 2050, aho igihombo mu bukungu kiri ku isongaTiriyari 100 z'amadolari.
Impamvu gusuzuma indwara ku gihe bidashoboka
Gukira kwa TB bishingiye ku kuntu yandura hakiri kare no ku miti ikwiye. Ariko, gukoresha imiti mibi byazamuye igituntu kidakira imiti myinshi (MDR-TB), bigatuma indwara zishobora kuvurwa zihinduka ibyago byica. Igiteye impungenge:
Igituntu kidakira imiti kigize 1/3 cy'impfu za AMR ku isi.
Abageze mu zabukuru bahura n'izamuka ry'impfu za AMR(byazamutseho 80% kuva mu 1990 mu bageze mu zabukuru).
Imihindagurikire y'ikirere ishoboraIkwirakwira rya AMR rirushaho kuba ribi ku kigero cya 2.4% mu 2050, bikagira ingaruka ku buryo butaringaniye ku turere dufite amikoro make.
OMS irasaba byihutirwa udushya mu gusuzuma vuba indwara kugira ngo harwanywe ikoreshwa nabi no kuziba icyuho mu kuvura
Macro & Micro-Test's Triple TB Kit Certified CE: Ibikoresho by'ubuhanga mu gihe cya AMR
Igisubizo cyacu gihuye n'ingamba za OMS zo gukumira AMR binyuze mu gutumaGupima icyarimwe ubwandu bw'igituntu + rifampicin (RIF) + ihangana rya isoniazid (INH)—ni ingenzi mu kugabanya indwara ya DR-TB.
Ibiranga by'ingenzi:
Umuvuduko n'Uburyo Butunganye: Ibisubizo mu masaha 2–2.5 hamwe n'uburyo bwo kubisobanura (hakenewe imyitozo mike).
Intego rusange:TB: gene ya IS6110
Ubudahangarwa bwa RIF: rpoB (507~533)
Ubudahangarwa bwa INH: InhA, AhpC, katG 315
Ubushobozi bwo kugaragaza ibyiyumvo bikabije: Ipima bagiteri nkeya nka 10/mL (TB) na bagiteri 150–200/mL kugira ngo imenye ibimenyetso by’ubudahangarwa bw’umubiri.
OMS-Iyubahiriza: Yujuje amabwiriza agenga imicungire ya DR-TB.
Guhuza kwagutse: Ikorana na sisitemu zikomeye za PCR (urugero, Bio-Rad CFX96, SLAN-96P/S).
Impamvu ibi ari ingenzi:
Kumenya vuba ibimenyetso by’uturemangingo tw’ubudahangarwa birinda ikoreshwa ry’imiti igabanya ubukana, bigabanya kwandura,
Guhamagarira Gukora
Guhuza kw'igituntu cyo kugaruka na AMR bisaba ibikoresho bihuza umuvuduko n'uburyo bworoshye. Ibikoresho byacu biziba iki cyuho—bigamije kwemeza ko ubuvuzi butangira neza, ku nshuro ya mbere.
Menya byinshi:
https://www.mmtest.com/mycobacterium-tuberculosis-nucleic-acid-and-rifampicin%ef%bc%8cisoniazid-resistance-product/
Twandikire:marketing@mmtest.com
#IVD #PCR #AMRCrisis #Kurwanya imiti #TB #ENDTB #MDRTB #Isuzuma #Ubuzima Mpuzamahanga #OMS #MacroMicroTest
Igihe cyo kohereza: Ugushyingo-25-2025